Home   >  
GPCR/G Protein
  >  
CCR

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

CCR

Chemical Structure Cat. No. Product Name CAS No.
CP 481715 Chemical Structure
 BCP18399 CP 481715 212790-31-3
CP 481715 a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseases.
BX 513 hydrochloride Chemical Structure
 BCP27909 BX 513 hydrochloride 1216540-18-9
BX-513 hydrochloride inhibits MIP-1α-induced intracellular calcium mobilization (IC50 = 2.5 μM).
UCB 35625 Chemical Structure
 BCP27911 UCB 35625 301648-08-8
UCB35625 is a potent chemokine CKR-1 (CCR1) and CKR-3 (CCR3) receptor antagonist.
ZK-756326 Chemical Structure
 BCP20725 ZK-756326 874911-96-3
ZK-756326 is a potent, selective and non-peptide CCR8 chemokine receptor agonist.
ZK756326 dihydrochloride Chemical Structure
 BCP29859 ZK756326 dihydrochloride 1780259-94-0
ZK756326 dihydrochloride is a nonpeptide chemokine receptor agonist for the CC chemokine receptor CCR8.
SB-297006 Chemical Structure
 BCP29726 SB-297006 58816-69-6
SB-297006 is a potent and selective CCR3 antagonist (IC50 = 39 nM).
GSK2239633A Chemical Structure
 BCP29621 GSK2239633A 1240516-71-5
GSK2239633A is a CC-chemokine receptor 4 (CCR4) antagonist, which inhibits the binding of [125I]-TARC to human CCR4 with a pIC50 of 7.96 ± 0.11.
Cenicriviroc Mesylate Chemical Structure
 BCP29615 Cenicriviroc Mesylate 497223-28-6
Cenicriviroc, also known as TAK-652 and TBR-652, is a dual CCR2/CCR5 antagonist.
TAK-779 Chemical Structure
 BCP28073 TAK-779 229005-80-5
TAK-779 is a highly potent and selective nonpeptide CCR5 antagonist with a IC50 value of 1.4 nM in the binding assay, TAK-779 also inhibited the replication of macrophage (M)-tropic HIV-1 (Ba-L strain) in both MAGI-CCR5 cells and PBMCs with EC50 values of 1.2 and 3.7 nM, respectively.
TAK 779 Chemical Structure
 BCP23716 TAK 779 263765-56-6
TAK-779 is a C-C chemokine receptor type 5 (CCR5) receptor antagonist potentially for the treatment of HIV infection.
123下一页共 26 条记录 1 / 3 页 
0086-13720134139